Vitamin D and multiple sclerosis

[1]  R. Jorde,et al.  No effect of supplementation with cholecalciferol on cytokines and markers of inflammation in overweight and obese subjects. , 2010, Cytokine.

[2]  William Wheeler,et al.  Genome-wide association study of circulating vitamin D levels , 2010, Human molecular genetics.

[3]  G. Ebers,et al.  Environmental factors and their timing in adult-onset multiple sclerosis , 2010, Nature Reviews Neurology.

[4]  M. Weller,et al.  CANCER RISK AMONG PATIENTS WITH MULTIPLE SCLEROSIS AND THEIR PARENTS , 2010, Neurology.

[5]  A. Ascherio,et al.  Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis , 2010, Multiple sclerosis.

[6]  A. Ascherio,et al.  Epidemiology of Multiple Sclerosis , 2009, Blue Books of Neurology.

[7]  H. Bischoff-Ferrari.  Vitamin D: what is an adequate vitamin D level and how much supplementation is necessary? , 2009, Best practice & research. Clinical rheumatology.

[8]  A. Wolk,et al.  Seasonal Genetic Influence on Serum 25-Hydroxyvitamin D Levels: A Twin Study , 2009, PloS one.

[9]  T. Chitnis,et al.  Body size and risk of MS in two cohorts of US women , 2009, Neurology.

[10]  J. Skripak.  Chromosome 17q21 Gene Variants Are Associated With Asthma and Exacerbations But Not Atopy in Early Childhood , 2009, Pediatrics.

[11]  M. Holick,et al.  25-Hydroxyvitamin D in cerebrospinal fluid during relapse and remission of multiple sclerosis , 2009, Multiple sclerosis.

[12]  F. Clerget-Darpoux,et al.  Season of birth and not vitamin D receptor promoter polymorphisms is a risk factor for multiple sclerosis , 2009, Multiple sclerosis.

[13]  Justin A. Spanier,et al.  Estrogen Controls Vitamin D3-Mediated Resistance to Experimental Autoimmune Encephalomyelitis by Controlling Vitamin D3 Metabolism and Receptor Expression1 , 2009, The Journal of Immunology.

[14]  C. Pfeiffer,et al.  Data advisory with regard to NHANES serum 25-hydroxyvitamin D data. , 2009, The American journal of clinical nutrition.

[15]  P. Menheere,et al.  Association Study on Two Vitamin D Receptor Gene Polymorphisms and Vitamin D Metabolites in Multiple Sclerosis , 2009, Annals of the New York Academy of Sciences.

[16]  A. Sadovnick,et al.  Gestational diabetes and multiple sclerosis. , 2009, Epidemiology.

[17]  Kerry Naunton,et al.  Peripheral blood regulatory T cell measurements correlate with serum vitamin D levels in patients with multiple sclerosis , 2009, Journal of Neuroimmunology.

[18]  P. Menheere,et al.  Vitamin D Status Is Positively Correlated with Regulatory T Cell Function in Patients with Multiple Sclerosis , 2009, PloS one.

[19]  T. Spector,et al.  Pigmentation and Vitamin D Metabolism in Caucasians: Low Vitamin D Serum Levels in Fair Skin Types in the UK , 2009, PloS one.

[20]  M. van Meurs,et al.  Serum leptin levels during pregnancy in multiple sclerosis , 2009, Multiple sclerosis.

[21]  D. Spiegelman,et al.  Prenatal and Perinatal Factors and Risk of Multiple Sclerosis , 2009, Epidemiology.

[22]  Ludwig Kappos,et al.  Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci , 2009, Nature Genetics.

[23]  Pablo Moscato,et al.  Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20 , 2009, Nature Genetics.

[24]  J. Knight,et al.  Multiple sclerosis and the major histocompatibility complex , 2009, Current opinion in neurology.

[25]  G. Nise,et al.  Occupational exposure to UV light and mortality from multiple sclerosis. , 2009, American journal of industrial medicine.

[26]  R. Hayes,et al.  Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk. , 2009, Carcinogenesis.

[27]  J. Correale,et al.  Immunomodulatory effects of Vitamin D in multiple sclerosis. , 2009, Brain : a journal of neurology.

[28]  T. Dwyer,et al.  Past environmental sun exposure and risk of multiple sclerosis: a role for the Cdx-2 Vitamin D receptor variant in this interaction , 2009, Multiple sclerosis.

[29]  R. D'Agostino,et al.  Genetic and non-genetic correlates of vitamins K and D , 2009, European Journal of Clinical Nutrition.

[30]  H. DeLuca,et al.  Enhancement of 1,25-dihydroxyvitamin D3-mediated suppression of experimental autoimmune encephalomyelitis by calcitonin , 2009, Proceedings of the National Academy of Sciences.

[31]  Carlos A Camargo,et al.  Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. , 2009, Archives of internal medicine.

[32]  Y. Lee,et al.  Vitamin D receptor TaqI, BsmI and ApaI polymorphisms and osteoarthritis susceptibility: a meta-analysis. , 2009, Joint, bone, spine : revue du rhumatisme.

[33]  C. Camargo,et al.  Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. , 2009, Archives of internal medicine.

[34]  P. Menheere,et al.  Fok-I vitamin D receptor gene polymorphism (rs10735810) and vitamin D metabolism in multiple sclerosis , 2009, Journal of Neuroimmunology.

[35]  J. Knight,et al.  Expression of the Multiple Sclerosis-Associated MHC Class II Allele HLA-DRB1*1501 Is Regulated by Vitamin D , 2009, PLoS genetics.

[36]  J. Brisson,et al.  Genetic polymorphisms of the vitamin D binding protein and plasma concentrations of 25-hydroxyvitamin D in premenopausal women. , 2009, The American journal of clinical nutrition.

[37]  C. Polman,et al.  Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women , 2009, Multiple sclerosis.

[38]  Elizabeth A Yetley,et al.  Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. , 2008, The American journal of clinical nutrition.

[39]  Frank B. Hu,et al.  Maternal Plasma 25-Hydroxyvitamin D Concentrations and the Risk for Gestational Diabetes Mellitus , 2008, PloS one.

[40]  T. Dwyer,et al.  Monthly Ambient Sunlight, Infections and Relapse Rates in Multiple Sclerosis , 2008, Neuroepidemiology.

[41]  A. Prentice.  Vitamin D deficiency: a global perspective. , 2008, Nutrition reviews.

[42]  J. Norris,et al.  Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in Hispanic and African Americans. , 2008, The Journal of clinical endocrinology and metabolism.

[43]  A. Reunanen,et al.  Serum Vitamin D and Subsequent Occurrence of Type 2 Diabetes , 2008, Epidemiology.

[44]  T. Dwyer,et al.  Melanocortin 1 receptor genotype, past environmental sun exposure, and risk of multiple sclerosis , 2008, Neurology.

[45]  A. Morris,et al.  Evidence for genetic regulation of vitamin D status in twins with multiple sclerosis , 2008, The American journal of clinical nutrition.

[46]  E. Yetley.  Assessing the vitamin D status of the US population. , 2008, The American journal of clinical nutrition.

[47]  A. Norman,et al.  From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. , 2008, The American journal of clinical nutrition.

[48]  A. Kessels,et al.  Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis , 2008, Multiple sclerosis.

[49]  M. Hernán,et al.  Temporal trends in the incidence of multiple sclerosis , 2008, Neurology.

[50]  K. Myhr,et al.  Vitamin D-dependent rickets as a possible risk factor for multiple sclerosis. , 2008, Archives of neurology.

[51]  J. Chang-Claude,et al.  The Gc2 Allele of the Vitamin D Binding Protein Is Associated with a Decreased Postmenopausal Breast Cancer Risk, Independent of the Vitamin D Status , 2008, Cancer Epidemiology Biomarkers & Prevention.

[52]  J. Chang-Claude,et al.  Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk , 2008, Breast Cancer Research.

[53]  J. Zerwekh.  Blood biomarkers of vitamin D status. , 2008, The American journal of clinical nutrition.

[54]  P. Vermersch,et al.  Cancer risk and impact of disease-modifying treatments in patients with multiple sclerosis , 2008, Multiple sclerosis.

[55]  B. Ames,et al.  Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction? , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[56]  M. Holick,et al.  Vitamin D deficiency: a worldwide problem with health consequences. , 2008, The American journal of clinical nutrition.

[57]  M. Holick,et al.  Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. , 2008, The Journal of clinical endocrinology and metabolism.

[58]  J. Knight,et al.  Association of Vitamin D–Related Information from a Telephone Interview with 25-Hydroxyvitamin D , 2008, Cancer Epidemiology Biomarkers & Prevention.

[59]  R. Reynolds,et al.  Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain , 2007, The Journal of experimental medicine.

[60]  K. Badenhoop,et al.  CYP2R1 (vitamin D 25‐hydroxylase) gene is associated with susceptibility to type 1 diabetes and vitamin D levels in Germans , 2007, Diabetes/metabolism research and reviews.

[61]  A. Auvinen,et al.  An association of serum vitamin D concentrations < 40 nmol/L with acute respiratory tract infection in young Finnish men. , 2007, The American journal of clinical nutrition.

[62]  R. Vieth,et al.  Safety of vitamin D3 in adults with multiple sclerosis. , 2007, The American journal of clinical nutrition.

[63]  S. Gabriel,et al.  Risk alleles for multiple sclerosis identified by a genomewide study. , 2007, The New England journal of medicine.

[64]  W. James Gauderman,et al.  Childhood sun exposure influences risk of multiple sclerosis in monozygotic twins , 2007, Neurology.

[65]  M. Holick.  Vitamin D deficiency. , 2007, The New England journal of medicine.

[66]  F. Williams,et al.  The genetics of osteoporosis. , 2007, Acta reumatologica portuguesa.

[67]  J. Erälinna,et al.  A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[68]  A. Ascherio,et al.  Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors , 2007, Annals of neurology.

[69]  T. Dwyer,et al.  The High Prevalence of Vitamin D Insufficiency across Australian Populations Is Only Partly Explained by Season and Latitude , 2007, Environmental health perspectives.

[70]  M. Holick,et al.  Factors that influence the cutaneous synthesis and dietary sources of vitamin D. , 2007, Archives of biochemistry and biophysics.

[71]  T. Dwyer,et al.  Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia , 2007, Journal of Neurology.

[72]  A. Ascherio,et al.  Environmental risk factors for multiple sclerosis. Part I: The role of infection , 2007, Annals of neurology.

[73]  T. Wilsgaard,et al.  Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle , 2007, Journal of Neurology.

[74]  E. Hyppönen,et al.  Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. , 2007, The American journal of clinical nutrition.

[75]  M. Wjst,et al.  A genome-wide linkage scan for 25-OH-D3 and 1,25-(OH)2-D3 serum levels in asthma families , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[76]  J. Fleming,et al.  The hygiene hypothesis and multiple sclerosis , 2007, Annals of neurology.

[77]  R. Strange,et al.  Studies of associations between disability in multiple sclerosis, skin type, gender and ultraviolet radiation , 2007, Multiple sclerosis.

[78]  A. Ascherio,et al.  Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. , 2006, JAMA.

[79]  S. Vukusic,et al.  Regional variations in the prevalence of multiple sclerosis in French farmers , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[80]  A. Norman,et al.  Minireview: vitamin D receptor: new assignments for an already busy receptor. , 2006, Endocrinology.

[81]  K. Spach,et al.  IL-10 Signaling Is Essential for 1,25-Dihydroxyvitamin D3-Mediated Inhibition of Experimental Autoimmune Encephalomyelitis1 , 2006, The Journal of Immunology.

[82]  W. Valdar,et al.  Sex ratio of multiple sclerosis in Canada: a longitudinal study , 2006, The Lancet Neurology.

[83]  L. Nyström,et al.  Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS) , 2006, Diabetologia.

[84]  M. Speeckaert,et al.  Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[85]  S. Madronich,et al.  Epidemic influenza and vitamin D , 2006, Epidemiology and Infection.

[86]  A. Ponsonby,et al.  Considering the potential benefits as well as adverse effects of sun exposure: can all the potential benefits be provided by oral vitamin D supplementation? , 2006, Progress in biophysics and molecular biology.

[87]  A. Uitterlinden,et al.  The Association between Common Vitamin D Receptor Gene Variations and Osteoporosis: A Participant-Level Meta-Analysis , 2006, Annals of Internal Medicine.

[88]  T. Dwyer,et al.  Validity and Reliability of Adult Recall of Past Sun Exposure in a Case-Control Study of Multiple Sclerosis , 2006, Cancer Epidemiology Biomarkers & Prevention.

[89]  W. Willett,et al.  Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. , 2006, The American journal of clinical nutrition.

[90]  L. Vécsei,et al.  The epidemiology of multiple sclerosis in Europe , 2006, European journal of neurology.

[91]  K. Badenhoop,et al.  Vitamin D-binding protein (DBP) gene polymorphism is associated with Graves' disease and the vitamin D status in a Polish population study. , 2006, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[92]  R. Marrie,et al.  Does multiple sclerosis–associated disability differ between races? , 2006, Neurology.

[93]  M. Wjst,et al.  Asthma families show transmission disequilibrium of gene variants in the vitamin D metabolism and signalling pathway , 2006, Respiratory research.

[94]  S. Harris,et al.  Vitamin D and African Americans. , 2006, The Journal of nutrition.

[95]  A. Ascherio,et al.  Infectious mononucleosis and risk for multiple sclerosis: A meta‐analysis , 2006, Annals of neurology.

[96]  H. Storm,et al.  Cancer risk among patients with multiple sclerosis: A population‐based register study , 2006, International journal of cancer.

[97]  P. Pozzilli,et al.  Low Levels of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 in Patients with Newly Diagnosed Type 1 Diabetes , 2005, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[98]  E. Lund,et al.  Daily Duration of Vitamin D Synthesis in Human Skin with Relation to Latitude, Total Ozone, Altitude, Ground Cover, Aerosols and Cloud Thickness , 2005, Photochemistry and photobiology.

[99]  K. Spach,et al.  Vitamin D3 Confers Protection from Autoimmune Encephalomyelitis Only in Female Mice1 , 2005, The Journal of Immunology.

[100]  G. Rice,et al.  A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing–remitting multiple sclerosis , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[101]  R. Rizzoli,et al.  Gene variants for osteoporosis and their pleiotropic effects in aging. , 2005, Molecular aspects of medicine.

[102]  L. Airas,et al.  25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis , 2005, Multiple sclerosis.

[103]  P. Vestergaard,et al.  Plasma concentrations of 25-Hydroxy-Vitamin D and 1,25-Dihydroxy-Vitamin D are Related to the Phenotype of Gc (Vitamin D-Binding Protein): A Cross-sectional Study on 595 Early Postmenopausal Women , 2005, Calcified Tissue International.

[104]  P. Lips,et al.  Estimates of optimal vitamin D status , 2005, Osteoporosis International.

[105]  D. Gilden.  Infectious causes of multiple sclerosis , 2005, The Lancet Neurology.

[106]  B. Hollis.  Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. , 2005, The Journal of nutrition.

[107]  R. Lea,et al.  VARIATION IN THE VITAMIN D RECEPTOR GENE IS ASSOCIATED WITH MULTIPLE SCLEROSIS IN AN AUSTRALIAN POPULATION , 2005, Journal of neurogenetics.

[108]  J L Haines,et al.  Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis , 2004, Neurology.

[109]  P. Rothwell,et al.  Timing of birth and risk of multiple sclerosis: population based study , 2004, BMJ : British Medical Journal.

[110]  M. Holick.  Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. , 2004, The American journal of clinical nutrition.

[111]  H. Panitch.  Influence of infection on exacerbations of multiple sclerosis , 2004, Annals of neurology.

[112]  M. Drezner,et al.  Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization. , 2004, The Journal of clinical endocrinology and metabolism.

[113]  A. Fryer,et al.  Susceptibility and outcome in MS , 2004, Neurology.

[114]  S. Sawcer,et al.  Four single nucleotide polymorphisms from the Vitamin D Receptor Gene in UK Multiple Sclerosis , 2004, Journal of Neurology.

[115]  Clare Baecher-Allan,et al.  Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis , 2004, The Journal of experimental medicine.

[116]  J. Attia,et al.  Haplotype analysis of VDR gene polymorphisms: a meta-analysis , 2004, Osteoporosis International.

[117]  A. Ponsonby,et al.  What affects your MS? Responses to an anonymous, Internet-based epidemiological survey , 2004, Multiple sclerosis.

[118]  M. Goldacre,et al.  Skin cancer in people with multiple sclerosis: a record linkage study , 2004, Journal of epidemiology and community health.

[119]  W. Willett,et al.  Vitamin D intake and incidence of multiple sclerosis , 2004, Neurology.

[120]  M. Wallin,et al.  Multiple sclerosis in US veterans of the Vietnam era and later military service: Race, sex, and geography , 2004, Annals of neurology.

[121]  R. McClelland,et al.  Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985–2000 , 2003, Neurology.

[122]  E. Fernández,et al.  Influence of vitamin D receptor gene polymorphisms and 25-hydroxyvitamin D on blood pressure in apparently healthy subjects , 2003, Journal of hypertension.

[123]  N. Risch,et al.  Twin concordance and sibling recurrence rates in multiple sclerosis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[124]  T. Dwyer,et al.  Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study , 2003, BMJ : British Medical Journal.

[125]  K. Spach,et al.  The immunological functions of the vitamin D endocrine system. , 2003, Cellular and molecular biology.

[126]  M. Holick.  Vitamin D: A millenium perspective , 2003, Journal of cellular biochemistry.

[127]  W. Willett,et al.  Calcium, vitamin D, milk consumption, and hip fractures: a prospective study among postmenopausal women. , 2003, The American journal of clinical nutrition.

[128]  J. Kira.  Multiple sclerosis in the Japanese population , 2003, The Lancet Neurology.

[129]  F. Cosman,et al.  Cytokine profile in patients with multiple sclerosis following vitamin D supplementation , 2003, Journal of Neuroimmunology.

[130]  P. Brachet,et al.  Treatment of experimental autoimmune encephalomyelitis in rat by 1,25-dihydroxyvitamin D3 leads to early effects within the central nervous system , 2003, Acta Neuropathologica.

[131]  T. Meehan,et al.  The vitamin D receptor is necessary for 1α,25-dihydroxyvitamin D3 to suppress experimental autoimmune encephalomyelitis in mice ☆ , 2002 .

[132]  J. Brundage,et al.  The Defense Medical Surveillance System and the Department of Defense serum repository: glimpses of the future of public health surveillance. , 2002, American journal of public health.

[133]  S. Kikuchi,et al.  No association of vitamin D-binding protein gene polymorphisms in Japanese patients with MS , 2002, Journal of Neuroimmunology.

[134]  F. Barkhof,et al.  Seasonal variation in immune measurements and MRI markers of disease activity in MS , 2002, Neurology.

[135]  H. DeLuca,et al.  Vitamin D: its role and uses in immunology 1 , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[136]  Elina Hyppönen,et al.  Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study , 2001, The Lancet.

[137]  David Clayton,et al.  Epidemiological methods for studying genes and environmental factors in complex diseases , 2001, The Lancet.

[138]  J. Goverman,et al.  Rag-1-dependent cells are necessary for 1,25-dihydroxyvitamin D3 prevention of experimental autoimmune encephalomyelitis , 2001, Journal of Neuroimmunology.

[139]  Terence Dwyer,et al.  Regional Variation in Multiple Sclerosis Prevalence in Australia and Its Association with Ambient Ultraviolet Radiation , 2001, Neuroepidemiology.

[140]  M. Rovaris,et al.  Effects of seasons on magnetic resonance imaging–measured disease activity in patients with multiple sclerosis , 2001, Annals of neurology.

[141]  T. Spector,et al.  Genetic Contribution to Bone Metabolism, Calcium Excretion, and Vitamin D and Parathyroid Hormone Regulation , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[142]  M. Holick,et al.  Decreased bioavailability of vitamin D in obesity. , 2000, The American journal of clinical nutrition.

[143]  S. Kikuchi,et al.  Vitamin D receptor gene polymorphism in multiple sclerosis and the association with HLA class II alleles , 2000, Journal of the Neurological Sciences.

[144]  R. Vieth,et al.  Vitamin D and seasonal fluctuations of gadolinium‐enhancing magnetic resonance imaging lesions in multiple sclerosis , 2000, Annals of neurology.

[145]  Mustafa Dosemeci,et al.  Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: a case-control study based on death certificates , 2000, Occupational and environmental medicine.

[146]  N. Risch,et al.  Genetic analysis of vitamin D related genes in Canadian multiple sclerosis patients , 2000, Neurology.

[147]  C. Gössl,et al.  Seasonal fluctuations of gadolinium‐enhancing magnetic resonance imaging lesions in multiple sclerosis , 2000, Annals of neurology.

[148]  F. Nashold,et al.  1,25-Dihydroxyvitamin D3 treatment decreases macrophage accumulation in the CNS of mice with experimental autoimmune encephalomyelitis , 2000, Journal of Neuroimmunology.

[149]  N. Jørgensen,et al.  The influence of smoking on vitamin D status and calcium metabolism , 1999, European Journal of Clinical Nutrition.

[150]  M. Hernán,et al.  Geographic variation of MS incidence in two prospective studies of US women , 1999, Neurology.

[151]  N Koch-Henriksen,et al.  The Danish Multiple Sclerosis Registry: a 50-year follow-up , 1999, Multiple sclerosis.

[152]  K. Miyasaka,et al.  Association of vitamin D receptor gene polymorphism with multiple sclerosis in Japanese , 1999, Journal of the Neurological Sciences.

[153]  R. Vieth,et al.  Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. , 1999, The American journal of clinical nutrition.

[154]  C. Rock,et al.  Demographic, dietary and lifestyle factors differentially explain variability in serum carotenoids and fat-soluble vitamins: baseline results from the sentinel site of the Olestra Post-Marketing Surveillance Study. , 1999, The Journal of nutrition.

[155]  M. Hutchinson,et al.  Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. , 1999, The New England journal of medicine.

[156]  B. Shatenstein,et al.  Nutritional factors in the aetiology of multiple sclerosis: a case-control study in Montreal, Canada. , 1998, International journal of epidemiology.

[157]  M. Hutchinson,et al.  Rate of Pregnancy-Related Relapse in Multiple Sclerosis , 1998 .

[158]  B. Weinshenker,et al.  The epidemiology of multiple sclerosis. , 1997, Mayo Clinic proceedings.

[159]  P. Brachet,et al.  1,25 Dihydroxyvitamin D3 Exerts Regional Effects in the Central Nervous System during Experimental Allergic Encephalomyelitis , 1996, Journal of neuropathology and experimental neurology.

[160]  H. DeLuca,et al.  1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[161]  B. Colombo,et al.  Multiple sclerosis and cancer in Norway. A retrospective cohort study , 1995, Journal of Neuroimmunology.

[162]  C. Martyn,et al.  Migrant studies in multiple sclerosis , 1995, Progress in Neurobiology.

[163]  R. Bouillon,et al.  Prevention of murine experimental allergic encephalomyelitis: cooperative effects of cyclosporine and 1 α, 25-(OH)2D3 , 1995, Journal of Neuroimmunology.

[164]  P. Metcalf,et al.  Serum 25-hydroxyvitamin D3 is related to physical activity and ethnicity but not obesity in a multicultural workforce. , 1995, Australian and New Zealand journal of medicine.

[165]  J. Kurtzke,et al.  MS epidemiology world wide. One view of current status , 1995, Acta neurologica Scandinavica. Supplementum.

[166]  M. Holick,et al.  Environmental factors that influence the cutaneous production of vitamin D 13 , 1995 .

[167]  J. Herbert,et al.  High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis , 1994, Neurology.

[168]  A. Sadovnick,et al.  Season of birth in multiple sclerosis , 1994, Acta neurologica Scandinavica.

[169]  T. Bergström,et al.  Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study , 1993, Journal of Neurology.

[170]  W. Page,et al.  Epidemiology of multiple sclerosis in U.S. veterans: V. Ancestry and the risk of multiple sclerosis , 1993, Annals of neurology.

[171]  B. Hollis,et al.  Determination of vitamin D status by radioimmunoassay with an 125I-labeled tracer. , 1993, Clinical chemistry.

[172]  C. Carlberg,et al.  Two nuclear signalling pathways for vitamin D , 1993, Nature.

[173]  R. Scragg,et al.  Plasma 25-hydroxyvitamin D3 and its relation to physical activity and other heart disease risk factors in the general population. , 1992, Annals of epidemiology.

[174]  P. Mortensen,et al.  Season of birth in multiple sclerosis , 1992, Acta neurologica Scandinavica.

[175]  J. Lemire,et al.  1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. , 1991, The Journal of clinical investigation.

[176]  A. Ziegler,et al.  Changes of vitamin D3 serum concentrations at the onset of immune-mediated type 1 (insulin-dependent) diabetes mellitus. , 1991, Diabetes research.

[177]  J. Mcleod,et al.  Multiple sclerosis in Australia and New Zealand: are the determinants genetic or environmental? , 1990, Journal of neurology, neurosurgery, and psychiatry.

[178]  G A Colditz,et al.  Food-based validation of a dietary questionnaire: the effects of week-to-week variation in food consumption. , 1989, International journal of epidemiology.

[179]  B. Hollis,et al.  In vivo threshold for cutaneous synthesis of vitamin D3. , 1989, The Journal of laboratory and clinical medicine.

[180]  K. Hyllested,et al.  Epidemiology of multiple sclerosis: incidence and prevalence rates in Denmark 1948–64 based on the Danish Multiple Sclerosis Registry , 1988, Acta neurologica Scandinavica.

[181]  D. English,et al.  The epidemiology of multiple sclerosis in three Australian cities: Perth, Newcastle and Hobart. , 1988, Brain : a journal of neurology.

[182]  M. Holick,et al.  Sunscreens suppress cutaneous vitamin D3 synthesis. , 1987, The Journal of clinical endocrinology and metabolism.

[183]  R. Wallace,et al.  Parameters related to 25-OH-D levels in a population-based study of women. , 1986, The American journal of clinical nutrition.

[184]  H. Whyte,et al.  Intravenous paraldehyde for seizure control in newborn infants , 1986, Neurology.

[185]  S. Epstein,et al.  Evidence for alteration of the vitamin D-endocrine system in obese subjects. , 1985, The Journal of clinical investigation.

[186]  G. Beebe,et al.  Epidemiology of multiple sclerosis in US veterans , 1985, Neurology.

[187]  H. Weiner,et al.  Prevention of experimental allergic encephalomyelitis (EAE) in the SJL/J mouse by whole body ultraviolet irradiation. , 1984, Journal of immunology.

[188]  W. Sibley,et al.  Seasonal variation of multiple sclerosis exacerbations in Arizona , 1983, Neurology.

[189]  S Greenland,et al.  Tests for interaction in epidemiologic studies: a review and a study of power. , 1983, Statistics in medicine.

[190]  H. M. Baum,et al.  The incidence and prevalence of reported multiple sclerosis , 1981, Annals of neurology.

[191]  B. Lund,et al.  Plasma 1,25-dihydroxyvitamin D levels in pregnancy and lactation. , 1979, Acta endocrinologica.

[192]  G. Beebe,et al.  Epidemiology of multiple sclerosis in U.S. veterans , 1979, Neurology.

[193]  R. Detels,et al.  Latitude, migration, and the prevalence of multiple sclerosis. , 1977, American journal of epidemiology.

[194]  C. M. Brooks,et al.  Infectious Mononucleosis at the United States Military Academy. A Prospective Study of a Single Class Over Four Years 1 , 1974, The Yale journal of biology and medicine.

[195]  J. Haddad,et al.  COMPETITIVE PROTEIN-BINDING RADIOASSAY FOR 25-HYDROXYCHOLECALCIFEROL1 , 1971 .

[196]  J. Smith,et al.  The turnover and transport of vitamin D and of a polar metabolite with the properties of 25-hydroxycholecalciferol in human plasma. , 1971, The Journal of clinical investigation.

[197]  K. Westlund.  DISTRIBUTION AND MORTALITY TIME TREND OF MULTIPLE SCLEROSIS AND SOME OTHER DISEASES IN NORWAY , 1970, Acta neurologica Scandinavica.

[198]  H. Rieder,et al.  The seasonal incidence of multiple sclerosis in Switzerland. , 1970, European neurology.

[199]  E. Mawer,et al.  Long Biological Half-life of Vitamin D3 and its Polar Metabolites in Human Serum , 1969, Nature.

[200]  M. Alter,et al.  Geographical considerations in multiple sclerosis. , 1967, Brain : a journal of neurology.

[201]  L. Kurland,et al.  Multiple sclerosis in New Orleans, Louisiana, and Winnipeg, Manitoba, Canada: follow-up of a previous survey in New Orleans, and comparison between the patient populations in the two communities. , 1967, Journal of chronic diseases.

[202]  H. Harrison.  A tribute to the first lady of public health (Martha M. Eliot). V. The disappearance of rickets. , 1966, American journal of public health and the nation's health.

[203]  A. Antonovsky,et al.  EPIDEMIOLOGIC STUDY OF MULTIPLE SCLEROSIS IN ISRAEL. I. AN OVERALL REVIEW OF METHODS AND FINDINGS. , 1965, Archives of neurology.

[204]  J. M. Sutherland,et al.  The prevalence of multiple sclerosis in Australia. , 1962, Brain : a journal of neurology.

[205]  E. Acheson,et al.  SOME COMMENTS ON THE RELATIONSHIP OF THE DISTRIBUTION OF MULTIPLE SCLEROSIS TO LATITUDE, SOLAR RADIATION, AND OTHER VARIABLES , 1960, Acta psychiatrica Scandinavica. Supplementum.

[206]  R. Swank,et al.  Multiple sclerosis in rural Norway its geographic and occupational incidence in relation to nutrition. , 1952, The New England journal of medicine.

[207]  L. Kurland.  The frequency and geographic distribution of multiple sclerosis as indicated by mortality statistics and morbidity surveys in the United States and Canada. , 1952, American journal of hygiene.

[208]  L. Snetselaar,et al.  Vitamin A and retinol intakes and the risk of fractures among participants of the Women's Health Initiative Observational Study. , 2009, The American journal of clinical nutrition.

[209]  O. Khan,et al.  Pediatric-onset multiple sclerosis in African-American black and European-origin white patients. , 2009, Pediatric neurology.

[210]  Claus Garbe,et al.  Epidemiology of melanoma and nonmelanoma skin cancer--the role of sunlight. , 2008, Advances in experimental medicine and biology.

[211]  E. Parra,et al.  Human pigmentation variation: evolution, genetic basis, and implications for public health. , 2007, American journal of physical anthropology.

[212]  S. Ozgoçmen,et al.  Vitamin D deficiency and reduced bone mineral density in multiple sclerosis: effect of ambulatory status and functional capacity , 2005, Journal of Bone and Mineral Metabolism.

[213]  Keith C. Norris,et al.  The prevalence of hypovitaminosis D among US adults: data from the NHANES III. , 2005, Ethnicity & disease.

[214]  M. Holick,et al.  Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. , 2003, The American journal of clinical nutrition.

[215]  H. DeLuca,et al.  1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. , 1998, The Journal of nutrition.

[216]  P. Galan,et al.  Prevalence of Vitamin D Insufficiency in an Adult Normal Population , 1997, Osteoporosis International.

[217]  A. Sadovnick,et al.  Genetics of Multiple Sclerosis , 1995, Neurologic clinics.

[218]  W. Willett,et al.  The use of a self-administered questionnaire to assess diet four years in the past. , 1988, American journal of epidemiology.

[219]  G. Beebe,et al.  Epidemiology of multiple sclerosis in US veterans: III. Migration and the risk of MS. , 1985, Neurology.

[220]  C. Chaimovitz,et al.  Increased incidence of nephrolithiasis (N) in lifeguards (LG) in Israel. , 1980, Advances in experimental medicine and biology.

[221]  S. Massry,et al.  Phosphate and Minerals in Health and Disease , 1980, Advances in Experimental Medicine and Biology.

[222]  P. Goldberg.  Multiple sclerosis: vitamin D and calcium as environmental determinants of prevalence. (A viewpoint). Part 1. Sunlight, dietary factors and epidemiology. , 1974 .

[223]  J. Haddad,et al.  Competitive protein-binding radioassay for 25-hydroxycholecalciferol. , 1971, The Journal of clinical endocrinology and metabolism.

[224]  M. Owsianowski,et al.  Epidemiological study of multiple sclerosis in western Poland. , 1969, European neurology.